Last update 27 Mar 2025

XT-150

Overview

Basic Info

Drug Type
Gene therapy
Synonyms
IL-10 transgene plasmid DNA, XT 101, XT 150
+ [2]
Target
Action
stimulants
Mechanism
IL-10R stimulants(Interleukin 10 receptor stimulants)
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2/3
First Approval Date-
RegulationFast Track (United States)
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
OsteoarthritisPhase 3
United States
-
InflammationPhase 2
United States
24 Feb 2022
Low Back PainPhase 2
United States
24 Feb 2022
ArthralgiaPhase 2
Australia
01 Oct 2021
Osteoarthritis, SpinePhase 2
Australia
01 Oct 2021
Osteoarthritis, KneePhase 2
United States
14 Feb 2020
Osteoarthritis, KneePhase 2
Australia
14 Feb 2020
PainPhase 2
Australia
14 Feb 2020
Amyotrophic Lateral SclerosisPhase 1
United States
01 Feb 2025
NeuralgiaPhase 1
Australia
14 Apr 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
75
(0.15mg XT-150)
musdvxtbkz(rlclydsopj) = cqmwgaaxnr wsfxrhzgbu (hcltqziwnd, 6.432)
-
25 Mar 2025
(0.45mg XT-150)
musdvxtbkz(rlclydsopj) = gkphsqteqe wsfxrhzgbu (hcltqziwnd, 5.717)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free